Back
Novartis AG 10K Form
Sell
45
NVS
Novartis AG
Last Price:
$97.09
Seasonality Move:
-2.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVS News And Ratings
See the #1 stock for the next 7 days that we like better than NVS
NVS Financial Statistics
Sales & Book Value
| Annual Sales: | $46.7B |
|---|---|
| Cash Flow: | $5.5B |
| Price / Cash Flow: | 15.92 |
| Annual Sales: | $21.67 |
| Price / Book: | 4.48 |
Profitability
| EPS (TTM): | 8.53000 |
|---|---|
| Net Income (TTM): | $17.6B |
| Gross Margin: | $34.2B |
| Return on Equity: | 41.89% |
| Return on Assets: | 17.33% |
Novartis AG Earnings Forecast
Key Novartis AG Financial Ratios
-
The Gross Profit Margin over the past 26 years for NVS is 73.27%.
-
The Selling, General & Administrative Expenses for NVS have been equal to 26.83% of Gross Profit Margin.
-
The Research & Development expenses have been 24.37% of Revenue.
-
The Interest Expense is 5.76% of Operating Income.
-
The Net Earning history of NVS is 31.83% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 17 years.
Novartis AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NVS |
| CUSIP: | 66987V |
| Website: | novartis.com |
Debt
| Debt-to-Equity Ratio: | 0.7 |
|---|---|
| Current Ratio: | 1.11 |
| Quick Ratio: | 0.79 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.68 |
|---|---|
| Forward P/E Ratio: | 11.66 |
NVS Technical Analysis vs Fundamental Analysis
Sell
45
Novartis AG (NVS)
is a Sell
Is Novartis AG a Buy or a Sell?
-
Novartis AG stock is rated a SellThe current Novartis AG [NVS] share price is $97.11. The Score for NVS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.